Cost-Effectiveness Analysis of OnabotulinumtoxinA (BOTOX®) for the Management of Urinary Incontinence in Adults with Neurogenic Detrusor Overactivity: A UK Perspective
Crossref DOI link: https://doi.org/10.1007/s40273-014-0245-8
Published Online: 2014-12-20
Published Print: 2015-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hamid, Rizwan
Loveman, Clara
Millen, Jim
Globe, Denise
Corbell, Catherine
Colayco, Danielle
Stanisic, Sanja
Gultyaev, Dmitry
License valid from 2014-12-20